By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Ocular Therapeutix, Inc. 

204 Second Avenue

Waltham  Massachusetts  02451  U.S.A.
Phone: 781-895-3235 Fax: 781-895-3236


SEARCH JOBS


Industry
Biotechnology






Company News
Ocular Therapeutix, Inc. (OCUL) To Present At Oppenheimer 25th Annual Healthcare Conference 12/2/2014 3:10:19 PM
Ora-CAC® Model Provided Platform For Recent Positive Phase 2 Data For Ocular Therapeutix, Inc. (OCUL)’s OTX-DP In Allergic Conjunctivitis 11/24/2014 9:42:08 AM
Ocular Therapeutix, Inc. (OCUL) Enrolls First Patients In Phase 2b Clinical Trial For Sustained Release Travoprost For The Treatment Of Glaucoma And Ocular Hypertension 11/12/2014 10:29:24 AM
Ocular Therapeutix, Inc. (OCUL) Reports Third Quarter 2014 Financial Results 11/12/2014 9:52:55 AM
Ocular Therapeutix, Inc. (OCUL) Announces Top-Line Results From Phase 2 Sustained Release Dexamethasone Trial For Allergic Conjunctivitis 11/12/2014 9:50:59 AM
Ocular Therapeutix, Inc. (OCUL) To Report Third Quarter 2014 Financial Results And Provide Business Updates On Wednesday, November 12, 2014 11/5/2014 10:11:03 AM
Ocular Therapeutix, Inc. (OCUL) To Participate In Two Investor Conferences In November 2014 10/31/2014 9:26:05 AM
Ocular Therapeutix, Inc. (OCUL) To Attend American Academy of Ophthalmology Annual Meeting In Chicago, Illinois 10/14/2014 3:06:21 PM
Ocular Therapeutix, Inc. (OCUL) Completes Enrollment In Phase 3 Sustained Release Dexamethasone Trials For Post-Operative Inflammation And Pain 10/8/2014 11:20:59 AM
Ocular Therapeutix, Inc. (OCUL) To Present At The 21st Annual NewsMakers In The Biotech Industry Investment Conference On Friday, September 26 9/16/2014 11:22:42 AM
1234
//-->